Alessandra Cesano insider trades: Puma Biotechnology (PBYI) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alessandra reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | PBYI | ↓ Sell | 62,150 | $9.12 | $567K | Direct | Sep 16, 2026 (2d) |
| Jul 18, 2025 | PBYI | ↓ Sell | 27,000 | $3.37 | $91K | Direct | Jul 22, 2025 (4d) |
| Jun 13, 2025 | PBYI | ↓ Sell | 12,150 | $3.40 | $41K | Direct | Jun 17, 2025 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PBYI insiders
Open-market trades in the last 12 months
About Alessandra Cesano's insider trades
Alessandra Cesano is a director at Puma Biotechnology (PBYI). Since Jun 13, 2025, Alessandra has reported no open-market purchases and 3 sales worth $699K on SEC Form 4. In the last 12 months: 1 sale ($567K).
Their filings also include grants and awards (16 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PBYI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.